The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Early and Late Acute Antibody-Mediated Rejection Differ Immunologically and in Response to Proteasome Inhibition
Abstract
BACKGROUND: The efficacy of plasma cell targeted therapies for antibody-mediated rejection (AMR) has not been defined in detail. The purpose of this study was to compare early and late acute AMR in terms of immunologic characteristics and responses with proteasome inhibitor (PI) therapy. METHODS: Renal transplant recipients with acute AMR were treated with PI-based regimens. Early acute AMR was defined as occurring within 6 months posttransplant. Immunodominant donor-specific antibody (iDSA) was defined as the DSA with the highest level. RESULTS: Results are expressed as early or late acute AMR. Thirty AMR episodes (13 early, 17 late) were treated in 12 and 16 patients. Early but not late AMR was associated with presensitization. Late AMR iDSA levels were higher, and specificities were primarily class II (DQ being most frequent). Early AMR patients demonstrated greater reduction in iDSA at 7, 14, and 30 days and at the posttreatment nadir (81.5%+21.2% vs. 51.4%+27.6%; P<0.01). Early AMR patients were more likely to demonstrate histologic resolution/improvement (87.5% vs. 53.8%; P=0.13). Both groups demonstrated significant improvement in renal function. CONCLUSIONS: Early and late AMR exhibit distinct immunologic characteristics and respond differently to PI therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duration of Humoral Immunity to Common Viral and Vaccine Antigens
Amanna, I. J., Carlson, N. E., & Slifka, M. K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066092 · Cited by 1,286
Cited by
Tait, B. D., Süsal, C., Gebel, H. M., Nickerson, P. W., Zachary, A. A., Claas, F. H. J., Reed, E. F., Bray, R. A., Campbell, P., Chapman, J. R., et al. (2013) · Transplantation · doi:10.1097/tp.0b013e31827a19cc · Cited by 787
A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection
Eskandary, F., Regele, H., Baumann, L., Bond, G., Kozakowski, N., Wahrmann, M., Hidalgo, L. G., Haslacher, H., Kaltenecker, C. C., Aretin, M.-B., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017070818 · Cited by 306
Aubert, O., Loupy, A., Hidalgo, L., Duong van Huyen, J.-P., Higgins, S., Viglietti, D., Jouven, X., Glotz, D., Legendre, C., Lefaucheur, C., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016070797 · Cited by 259
Metadata
- Authors
- Walsh, R. C., Brailey, P., Girnita, A., Alloway, R. R., Shields, A. R., Wall, G. E., Sadaka, B. H., Cardi, M., Tevar, A., Govil, A., Mogilishetty, G., Roy-Chaudhury, P., & Woodle, E. S.
- Venue
- Transplantation
- Published
- 2011-06-15
- Volume
- 91
- Issue
- 11
- Pages
- 1218-1226
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W1972879732
- Cited by
- 162
- References
- 1
- FWCI
- 12.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early and Late Acute Antibody-Mediated Rejection Differ Immunologically and in Response to Proteasome Inhibition. https://app.cochat.ai/papers/10.1097/tp.0b013e318218e901
- The paper
- Walsh, R. C., Brailey, P., Girnita, A., Alloway, R. R., Shields, A. R., Wall, G. E., Sadaka, B. H., Cardi, M., Tevar, A., Govil, A., Mogilishetty, G., Roy-Chaudhury, P., & Woodle, E. S. (2011). Early and Late Acute Antibody-Mediated Rejection Differ Immunologically and in Response to Proteasome Inhibition. Transplantation. https://doi.org/10.1097/tp.0b013e318218e901
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.